Viking Therapeutics: Market Rightly Excited by GLP-1 Promise — A Buy Ahead Of Data (VKTX)

This article was written by

Follow

Analyst Disclosure: We do not/do not have shares, options or similar derivative positions in any of the mentioned companies, but we can initiate a beneficial long position by purchasing shares or purchasing call options or similar derivatives in VKTX within the next 72 hours. I wrote this article myself and it expresses my own opinions. I receive no compensation for this (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Looking for Alpha’s reveal: Past performance is no guarantee of future results. No recommendation or advice is given to determine whether any investment is suitable for any particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, a US broker or investment adviser, or an investment bank. Our analysts are third-party authors that include both professional and individual investors who may not be authorized or certified by any institute or regulatory body.